Results 231 to 240 of about 694,198 (334)

Synthetic Kefir Based on Fermentation of Natural Kefir and Koumiss Core Microbial Species Reveals Microbial Interactions and Gene Exchanges in Natural Kefir

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
ABSTRACT Kefir and koumiss are both traditional alcoholic fermented milk drinks made from the fermentation of various probiotics and yeasts. The complex microbial composition of kefir and koumiss has hindered the expansion of their consumption in global markets.
Zhenyi Qiao   +9 more
wiley   +1 more source

Edible Seeds in the Fight Against Hypertension: A Review of In Vitro, In Vivo, and Clinical Evidences With a Mechanistic Insight of Bioactive Compounds

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
The presented review provides the potential antihypertensive benefits of traditionally employed edible seeds, presenting new perspectives and avenues for future research. ABSTRACT Hypertension, often referred to as a silent killer, is responsible for 7.5 million deaths, representing approximately 12.8% of all global mortality.
Jinmin Shi   +8 more
wiley   +1 more source

HCN1 Channels Contribute to the Effects of Amnesia and Hypnosis but not Immobility of Volatile Anesthetics

open access: yesAnesthesia and Analgesia, 2015
Cheng Zhou   +8 more
semanticscholar   +1 more source

Modulation of the Volatile Profile of Cardamom (Elettaria cardamomum) Essential Oil by Non‐Thermal Instant Controlled Pressure Drop (DIC) Technology: A Novel Approach in Food Processing

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
This work highlighted the potential of instant controlled pressure drop technology as a possible modulator of specific compounds within complex plant extracts such as essential oil. Both time and temperature had important effects on the yield of specific compounds, underscoring the importance of tailoring them to maximize metabolites of interest. Among
Giselle Dení Teresa‐Martínez   +4 more
wiley   +1 more source

A Novel NLRP3 Inhibitor AMS‐17 Rescues Deficits in Long‐Term Potentiation Following Mild Traumatic Brain Injury in Adult C57Bl/6 Mice

open access: yesHippocampus, Volume 36, Issue 1, January 2026.
ABSTRACT Traumatic brain injury (TBI) is a leading cause of long‐term disability, with limited effective treatment options. A key factor of TBI pathophysiology is neuroinflammation, which can involve the activation of the nucleotide‐binding domain leucine‐rich repeat protein 3 (NLRP3) inflammasome. Aberrant inflammation following injury has the ability
Eric Eyolfson   +7 more
wiley   +1 more source

"A real-world evidence" in reduction of volatile anesthetics by BIS-guided anesthesia. [PDF]

open access: yesSci Rep, 2020
Poon YY   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy